Effect of chronic sodium nitrite therapy on monocrotaline-induced pulmonary hypertension

被引:27
作者
Pankey, Edward A. [1 ]
Badejo, Adeleke M. [1 ]
Casey, David B. [1 ]
Lasker, George F. [1 ]
Riehl, Russel A. [1 ]
Murthy, Subramanyam N. [1 ]
Nossaman, Bobby D. [1 ,2 ]
Kadowitz, Philip J. [1 ]
机构
[1] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA
[2] Ochsner Med Ctr, Crit Care Med Sect, Dept Anesthesiol, New Orleans, LA 70121 USA
来源
NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 2012年 / 27卷 / 01期
关键词
Pulmonary vascular bed; Pulmonary hypertension/therapy; Right ventricular hypertrophy; Sodium nitrite; Nitric oxide; Monocrotaline; MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; VASCULAR SMOOTH-MUSCLE; ARTERIAL-HYPERTENSION; GUANYLATE-CYCLASE; XANTHINE OXIDOREDUCTASE; VASODILATOR RESPONSES; GLYCERYL TRINITRATE; OXIDE SYNTHASE; DEPENDENT VASODILATION; SIGNALING MOLECULE;
D O I
10.1016/j.niox.2012.02.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pulmonary hypertension (PH) is a rare disorder that without treatment is progressive and often fatal within 3 years. The treatment of PH involves the use of a diverse group of drugs and lung transplantation. Although nitrite was once thought to be an inactive metabolite of endothelial-derived nitric oxide (NO), there is increasing evidence that nitrite may be useful in the treatment of PH, but the mechanism by which nitrite exerts its beneficial effect remains uncertain. The purpose of this study was to investigate the effect of chronic sodium nitrite treatment in a PH model in the rat. Following induction of PH with a single injection of monocrotaline, 60 mg: daily ip injections of sodium nitrite (3 mg/kg) starting on day 14 and continuing for 21 days, resulted in a significantly lower pulmonary arterial pressure on day 35 when compared to values in untreated animals with monocrotaline-induced PH. In monocrotaline-treated rats, daily treatment with ip nitrite injections for 21 days decreased right ventricular mass and pathologic changes in small pulmonary arteries. Nitrite therapy did not change systemic arterial pressure or cardiac output when values were measured on day 35. The decreases in pulmonary arterial pressure in response to iv injections of sodium nitroprusside, sodium nitrite, and BAY 41-8543 were not different in rats with monocrotaline-induced pulmonary hypertension and rats with chronic nitrite therapy when compared to responses in animals in which pulmonary arterial pressure was increased with U46619. These findings are consistent with the hypothesis that the mechanisms that convert nitrite to vasoactive NO, activate soluble guanylyl cyclase and mediate the vasodilator response to NO or an NO derivative are not impaired. The present data are consistent with the results of a previous study in monocrotaline-induced PH in which systemic arterial pressure and cardiac output were not evaluated and are consistent with the hypothesis that nitrite is effective in the treatment of monocrotaline-induced PH in the rodent. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 81 条
  • [1] NITRIC-OXIDE ACTIVATES GUANYLATE CYCLASE AND INCREASES GUANOSINE 3'-5'-CYCLIC MONOPHOSPHATE LEVELS IN VARIOUS TISSUE PREPARATIONS
    ARNOLD, WP
    MITTAL, CK
    KATSUKI, S
    MURAD, F
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (08) : 3203 - 3207
  • [2] In vitro activation of soluble guanylyl cyclase and nitric oxide release: A comparison of NO donors and NO mimetics
    Artz, JD
    Toader, V
    Zavorin, SI
    Bennett, BM
    Thatcher, GRJ
    [J]. BIOCHEMISTRY, 2001, 40 (31) : 9256 - 9264
  • [3] Mitochondrial aldehyde dehydrogenase mediates vasodilator responses of glyceryl trinitrate and sodium nitrite in the pulmonary vascular bed of the rat
    Badejo, Adeleke M., Jr.
    Hodnette, Chris
    Dhaliwal, Jasdeep S.
    Casey, David B.
    Pankey, Edward
    Murthy, Subramanyam N.
    Nossaman, Bobby D.
    Hyman, Albert L.
    Kadowitz, Philip J.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2010, 299 (03): : H819 - H826
  • [4] Beretta M, 2008, J BIOL CHEM, V283, P17873, DOI [10.1074/jbc.M801182200, 10.1074/jbc.M804001200]
  • [5] Vascular Bioactivation of Nitroglycerin Is Catalyzed by Cytosolic Aldehyde Dehydrogenase-2
    Beretta, Matteo
    Woelkart, Gerald
    Schernthaner, Michaela
    Griesberger, Martina
    Neubauer, Regina
    Schmidt, Kurt
    Sacherer, Michael
    Heinzel, Frank R.
    Kohlwein, Sepp D.
    Mayer, Bernd
    [J]. CIRCULATION RESEARCH, 2012, 110 (03) : 385 - U52
  • [6] Nitric oxide (NO) - Biogeneration, regulation, and relevence to human diseases
    Bian, K
    Murad, F
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2003, 8 : D264 - D278
  • [7] In vitro and in vivo kinetic handling of nitrite in blood: effects of varying hemoglobin oxygen saturation
    Blood, Arlin B.
    Power, Gordon G.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 293 (03): : H1508 - H1517
  • [8] Inhaled Nitrite Reverses Hemolysis-Induced Pulmonary Vasoconstriction in Newborn Lambs Without Blood Participation
    Blood, Arlin B.
    Schroeder, Hobe J.
    Terry, Michael H.
    Merrill-Henry, Jeanette
    Bragg, Shannon L.
    Vrancken, Kurt
    Liu, Taiming
    Herring, Jason L.
    Sowers, Lawrence C.
    Wilson, Sean M.
    Power, Gordon G.
    [J]. CIRCULATION, 2011, 123 (06) : 605 - U136
  • [9] NITRIC OXIDE-DEPENDENT LONG-TERM POTENTIATION IS BLOCKED BY A SPECIFIC INHIBITOR OF SOLUBLE GUANYLYL CYCLASE
    BOULTON, CL
    SOUTHAM, E
    GARTHWAITE, J
    [J]. NEUROSCIENCE, 1995, 69 (03) : 699 - 703
  • [10] BRAUGHLER JM, 1979, J BIOL CHEM, V254, P2450